Shenzhen Hepalink Pharmaceutical Group Co. Ltd. Announces Date for First Extraordinary General Meeting
I'm PortAI, I can summarize articles.
Shenzhen Hepalink Pharmaceutical Group Co. Ltd. will hold its first extraordinary general meeting of 2025 on December 16 at L’Hermitage Hotel in Shenzhen. Shareholders will vote on key proposals, including the abolition of the Supervisory Committee, amendments to the Articles of Association, internal governance measures, and the election of an independent non-executive director.
Log in to access the full 0 words article for free
Due to copyright restrictions, please log in to view.
Thank you for supporting legitimate content.
Source: Reuters The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
Post your comment
No Comments